EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 6 July 2023

News

NIRO: Navigating Innovation & Research Opportunities
04 July 2023

A tool to help the private and public sector, not-for-profit organisations, and academia identify relevant R&I initiatives... Read more

Blogs

Prevention is the best medicine (Guest Blog)
06 July 2023 - Cyril Schiever

Let’s all reflect on what each of us can do in the fight against cancer. And then let’s do it! Read more

Innovation to safeguard sustainability of cancer care (Guest Blog)
06 July 2023 - Rene Medema

Europe’s oncology workforce shortage will put patients at risk unless urgent action is taken to make cancer care more... Read more

Why is health data access important to R&D?

Health data is the fuel driving the research and innovation engine of healthcare. There is significant scope for the EHDS to improve data sharing in the EU. By doing this, the EU could strengthen public health, deliver better health outcomes for citizens and promote their well-being. Have a look at our latest infographic on the topic here.

Events

Rethinking Alzheimer’s disease: Moving towards a new Alzheimer’s disease detection and diagnosis...
26 September 2023 (Online)

Moving towards a new Alzheimer’s disease detection and diagnosis pathway Read more

DIA Medical Information and Communications Conference
27 September 2023 (Brussels)

Engage and exchange with the biggest medical information community in Europe Read more

How can policymakers help create a healthier Europe?

With the 2024 European Parliament elections coming up, the EU Health Coalition spotlights the need for a robust and integrated strategy for health policy at the European level, building on a “One Health” approach. Read here the Coalition's 5 recommendations to ensure Europeans live healthier lives and the EU regains its place at the forefront of innovation.

What we are reading

EU rail industry warns over proposed ban on ‘forever chemicals’
On 03 July 2023 (Financial Times)

Pharmaceutical companies say that PFAS are needed not just in medicines themselves but in the equipment used for... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu